Molecular typing relies on molecular genetic tests and is not nevertheless routinely offered. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-sixty seven might be practical,